For once, this isnât hyperbole. Metastatic pancreatic cancer hasnât had a meaningful new treatment in literally decades - itâs been brutal chemotherapy or slightly less brutal chemotherapy.
The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.
It wonât cure people with metastatic disease, but it will help a lot live better lives for longer.
>Metastatic pancreatic cancer hasnât had a meaningful new treatment in literally decades
Not true. The folfirinox chemo regimen was invented a couple of years ago, and it significantly increased the life expectancy and quality of life for terminal pancreatic cancer patients.[0]
> It wonât cure people with metastatic disease, but it will help a lot live better lives for longer.
Cancer is a problem that can be solved, and it needs to be solved asap. Cancer too often gets either relegated to "Actually, statistically it's very unlikely" by people who don't have it or stylized to the God of Death that unlike other illness we won't solve anytime soon. There is no time to be lost tackling with AI. Dario gets it. Had cancer himself and his father passed away from it.
The thing that makes cancer such a hard problem is that cancer is really a collection of diseases. There's, what, like over a hundred of them? And one organ can produce several unrelated cancers too. I do hope AI will actually be able to figure out the commonalities between all of them and a potential path for a possible even somewhat-universal solution, but I at least don't even know if a universal "cure" is even possible. Granted, my knowledge of biology with respect to cancers is pretty limited.
Often pancreatic cancer is discovered only after it has spread. If this can treat it at that point it turns the disease from a death sentence to a lifeline until more research can come to fruition
Everything is relative. A few more months of life with less pain and more energy to spend it with family surely is a breakthrough for many patients and for the doctors treating them.
You're awfully negative about what a lot of people here see as a breakthrough. Can you be more descriptive about why you don't agree this constitutes a substantial difference other than saying you disagree and dismissing others' opinion?
I donât think you have ever had to witness somebody undergoing chemotherapy. An alternative, if available is almost always better, and certainly less painful.
> Treatment-related adverse events that led to treatment discontinuation occurred in 1.2% of the patients in the daraxonrasib group and in 11.2% of those in the chemotherapy group.
That's a huge reduction in side effects bad enough to stop treatment.
For once, this isnât hyperbole. Metastatic pancreatic cancer hasnât had a meaningful new treatment in literally decades - itâs been brutal chemotherapy or slightly less brutal chemotherapy.
The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.
It wonât cure people with metastatic disease, but it will help a lot live better lives for longer.
>Metastatic pancreatic cancer hasnât had a meaningful new treatment in literally decades
Not true. The folfirinox chemo regimen was invented a couple of years ago, and it significantly increased the life expectancy and quality of life for terminal pancreatic cancer patients.[0]
[0]https://www.nejm.org/doi/10.1056/NEJMoa1011923
> It wonât cure people with metastatic disease, but it will help a lot live better lives for longer.
Cancer is a problem that can be solved, and it needs to be solved asap. Cancer too often gets either relegated to "Actually, statistically it's very unlikely" by people who don't have it or stylized to the God of Death that unlike other illness we won't solve anytime soon. There is no time to be lost tackling with AI. Dario gets it. Had cancer himself and his father passed away from it.
The thing that makes cancer such a hard problem is that cancer is really a collection of diseases. There's, what, like over a hundred of them? And one organ can produce several unrelated cancers too. I do hope AI will actually be able to figure out the commonalities between all of them and a potential path for a possible even somewhat-universal solution, but I at least don't even know if a universal "cure" is even possible. Granted, my knowledge of biology with respect to cancers is pretty limited.
Cancer is a mutation of cells. There might be 100 known cancers that present in humans, but in theory any mutation can lead to cancer.
Unless we can reliably sign our cells like we do our binaries, we ain't "solving" cancer.
We solve the 100 we very well could be solving cancer for 99.5% of folks while still not âsolvingâ cancer.
> For once, this isnât hyperbole.
Am I missing something?
From other sources:
> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.
Doubling life expectancy on a form of cancer infamous as a death sentence.
I don't see that as a breakthrough.
Merely counting months does not do much - you'd have to count the quality of these months too.
An effect that large is a medical breakthrough regardless of your opinion of the treatment impact.
Often pancreatic cancer is discovered only after it has spread. If this can treat it at that point it turns the disease from a death sentence to a lifeline until more research can come to fruition
Everything is relative. A few more months of life with less pain and more energy to spend it with family surely is a breakthrough for many patients and for the doctors treating them.
But where does it imply less pain? Plus, which pain exactly? Chemotherapy also leads to pain. Prolonging treatment can cause more pain then.
I don't see that as a breakthrough.
You're awfully negative about what a lot of people here see as a breakthrough. Can you be more descriptive about why you don't agree this constitutes a substantial difference other than saying you disagree and dismissing others' opinion?
I donât think you have ever had to witness somebody undergoing chemotherapy. An alternative, if available is almost always better, and certainly less painful.
It sucks less than existing chemo:
> Treatment-related adverse events that led to treatment discontinuation occurred in 1.2% of the patients in the daraxonrasib group and in 11.2% of those in the chemotherapy group.
That's a huge reduction in side effects bad enough to stop treatment.
https://www.nejm.org/doi/full/10.1056/NEJMoa2605555?
Thatâs like a 100% increase over standard of care. Or a two-order-of-magnitude improvement.
It's a 2Ă increase. Huge, but not two orders of magnitude, which would be a 100Ă increase.
In base sqrt(2) it is two orders I guess.
People who pay a lot of attention to US news might know this as the therapy former senator and UF president Ben Sasse is taking.
I do hope to see more progress on medicine with AI.
If we can prove GRH with AI we really should be able to cure cancer.
In case others are wondering, it looks like this is a different story than this recent one:
Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)